CytoSorbents Reports Record Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Cytosorbents (CTSO) Tops Q2 EPS by 3c
August 6, 2019 5:04 PM EDTCytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.11 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More
